← Leaderboards
Austin L Brown
Baylor College Of Medicine
$3,048,574
Attributed
$4,602,168
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,602,168 · 6
By mechanism
R01$3,107,189 · 2
K07$758,292 · 1
U54$393,351 · 1
P20$343,336 · 2
Top collaborators
- Avner Meoded3 shared
- Kimberly Pauline Raghubar3 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Michael E. Scheurer$13,029,347
- Maria Monica Gramatges$5,640,613
- Lisa Schum Kahalley$10,210,510
- Philip Lupo$9,426,109
- Karen R Rabin$5,475,660
Others in their field
Other Emerging Leaders on “Childhood Acute Lymphocytic Leukemia”
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,557,384
- Adam De Smith · University Of Southern California$5,277,579
- Karen R Rabin · Baylor College Of Medicine$4,946,686
- Amanda M Schalk · Enzyme By Design, Inc.$3,243,476
Research focus
Childhood Acute Lymphocytic LeukemiaCohortSamplingResourcesAcute Lymphocytic LeukemiaDiagnosisChildTreatment-Related ToxicityLeukemia Acute Lymphoblastic ChemotherapyQuality Of LifePhenotypeResponseInheritedInnovationGenetic VariationChemotherapyGenomicsGeneticBiological MarkersProspectiveEpidemiologyFunctional DisorderPathway InteractionsHigh Risk
Grant awards (15)
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia$608,609
R01 · FY2025 · CA · contact PI
Project 1: Understanding population-based disparities in treatment-associated hepatotoxicity during ALL therapy$393,351
U54 · FY2025 · CA · contact PI
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.$1
R01 · FY2025 · CA
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia$614,625
R01 · FY2024 · CA · contact PI
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.$610,229
R01 · FY2024 · CA
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia$659,161
R01 · FY2023 · CA · contact PI
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.$614,564
R01 · FY2023 · CA
Etiology and impact of ethnic disparities in therapy-associated hepatotoxicity among children and adolescents treated for ALL$67,644
P20 · FY2023 · CA · contact PI
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia$148,663
K07 · FY2022 · CA · contact PI
Etiology and impact of ethnic disparities in therapy-associated hepatotoxicity among children and adolescents treated for ALL$88,547
P20 · FY2022 · CA · contact PI
Etiology and impact of ethnic disparities in therapy-associated hepatotoxicity among children and adolescents treated for ALL$187,145
P20 · FY2021 · CA · contact PI
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia$150,823
K07 · FY2021 · CA · contact PI
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia$151,903
K07 · FY2020 · CA · contact PI
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia$140,860
K07 · FY2019 · CA · contact PI
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia$166,043
K07 · FY2018 · CA · contact PI